FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
LANREOTIDE ACETATE
lanreotide acetate
Peak
Gen Pharmaceuticals
SUBCUTANEOUS · SOLUTION
wellmoderately differentiated+2
2021
PeptideNDA
30/100
LARGON
propiomazine hydrochloride
LOE Approaching
Hikma
INJECTION · INJECTABLE
1960
NDA
30/100
LARIAM
mefloquine hydrochloride
LOE Approaching
Roche
ORAL · TABLET
1989
NDA
30/100
LARODOPA
levodopa
LOE Approaching
Roche
ORAL · TABLET
1970
NDA
30/100
LAROTID
amoxicillin
LOE Approaching
GSK
ORAL · FOR SUSPENSION
1974
NDA
30/100
LASIX
furosemide
LOE Approaching
Sanofi
ORAL · SOLUTION
1977
NDA
30/100
LASIX
furosemide
LOE Approaching
Sanofi
INJECTION · INJECTABLE
1968
NDA
30/100
LASIX
furosemide
LOE Approaching
Bausch Health
ORAL · TABLET
cirrhosis of the liverrenal disease+2
1966
NDA
30/100
LASIX ONYU
furosemide
Launch
Innovation Pharmaceuticals
SUBCUTANEOUS · SOLUTION
edema in adult patients with chronic heart failure
2025
NDA
30/100
LATISSE
bimatoprost
LOE Approaching
AbbVie
TOPICAL · SOLUTION/DROPS
hypotrichosis of the eyelashes by increasing their growth including lengththickness+1
2008
NDA
30/100
LERITINE
anileridine hydrochloride
LOE Approaching
Merck & Co.
ORAL · TABLET
1957
NDA
30/100
LESCOL
fluvastatin sodium
LOE Approaching
Novartis
ORAL · CAPSULE
1993
NDA
30/100
LESCOL XL
fluvastatin sodium
LOE Approaching
Novartis
ORAL · TABLET, EXTENDED RELEASE
2000
NDA
30/100
LEUCOVORIN CALCIUM
leucovorin calcium
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1952
NDA
30/100
LEUCOVORIN CALCIUM
leucovorin calcium
LOE Approaching
ORAL · TABLET
1980
NDA
30/100
LEUKERAN
chlorambucil
LOE Approaching
Viatris (2)
ORAL · TABLET
1957
NDA
30/100
LEUPROLIDE ACETATE FOR DEPOT SUSPENSION
leuprolide acetate
Peak
Gen Pharmaceuticals
INTRAMUSCULAR · FOR SUSPENSION
advanced prostate cancerprostate cancer
2018
NDA
30/100
LEUSTATIN
cladribine
LOE Approaching
Johnson & Johnson
INJECTION · INJECTABLE
1993
NDA
30/100
LEVAQUIN
levofloxacin
LOE Approaching
Johnson & Johnson
INJECTION · INJECTABLE
1996
SMNDA
30/100
LEVAQUIN
levofloxacin
LOE Approaching
Johnson & Johnson
ORAL · SOLUTION
2004
SMNDA
30/100
LEVAQUIN
levofloxacin
LOE Approaching
Johnson & Johnson
ORAL · TABLET
1996
SMNDA
30/100
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
levofloxacin
LOE Approaching
Johnson & Johnson
INJECTION · INJECTABLE
1996
SMNDA
30/100
LEVATOL
penbutolol sulfate
LOE Approaching
ORAL · TABLET
1987
NDA
30/100
LEVETIRACETAM IN SODIUM CHLORIDE
levetiracetam
Peak
R-Pharm US
INTRAVENOUS · INJECTABLE
epilepsy
2011
NDA
30/100
← PreviousPage 95 of 277Next →